Heart Failure and Pulmonary Hypertension Registry
Study Status
Open to Enrollment
Study Description
This study will follow patients seen in the in/outpatient setting at Weill Cornell Medical College with current or past diagnosis of heart failure (HF) and pulmonary hypertension (PH). The study has three specific aims:
- To determine the patterns of patient self-care behaviors among patients with HF and PH
- To determine the impact of patient self-care behaviors on HF-related quality of life
- To determine the impact of patient self-care on downstream rehospitalization and major adverse cardiac events after one year.
All enrolled subjects will complete a short, 10-minute survey describing their self-care behaviors and health-related quality of life at the beginning of the study. Study personnel will review patient charts to analyze cardiac risk factors, signs and symptoms of HF, vital signs, cardiac comorbidities (including coronary artery disease and arrhythmia), non-cardiac comorbidities (including kidney insufficiency and chronic obstructive pulmonary disease), and imaging and test parameters (including but not limited to ejection fraction, eschemic burden, pulmonary artery pressures and cardiac output). Subjects will then be contacted one year later so that researchers can obtain follow-up quality-of-life, cardiac and heart failure-related rehospitalization and all-cause mortality. No further participation will be required other than the initial surveys and follow-up contacts done by phone, mail, email or at a routine clinic visit. Subjects will not undergo any research-specific tests or procedures above and beyond usual care with the exception of the quality-of-life and the self-care behavior questionnaires at time of enrollment.
Key Eligibility
Inclusion criteria:
- All inpatients and outpatients at Weill Cornell Medical Center whose principal or consulting attending physician is Dr. Sobol or Dr. Horn (co-investigator on this study) who have been diagnosed with HF (either with preserved or depressed ejection fraction) and/or pulmonary hypertension will be eligible to participate.
- Patient inability to consent or refusal to participate
Principal Investigator
Contact
- Irina Sobol, MD
- (212) 746-1725
- [email protected]
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Robert Hagerty
Subject Recruitment Manager
Tel: (646) 962-9340
[email protected]
